View Financial HealthIDEX Biometrics 配当と自社株買い配当金 基準チェック /06IDEX Biometrics配当金を支払った記録がありません。主要情報n/a配当利回り-13.5%バイバック利回り総株主利回り-13.5%将来の配当利回りn/a配当成長n/a次回配当支払日n/a配当落ち日n/a一株当たり配当金n/a配当性向n/a最近の配当と自社株買いの更新更新なしすべての更新を表示Recent updatesお知らせ • Apr 29IDEX Biometrics ASA has filed a Follow-on Equity Offering in the amount of NOK 19.999997 million.IDEX Biometrics ASA has filed a Follow-on Equity Offering in the amount of NOK 19.999997 million. Security Name: Shares Security Type: Common Stock Securities Offered: 2,424,242 Price\Range: NOK 8.25 Transaction Features: Rights Offeringお知らせ • Mar 06IDEX Biometrics ASA announced that it expects to receive NOK 90.000001 million in fundingIDEX Biometrics ASA announced a private placement to issue NOK 90,000,000 to ID centric in two tranches on March 5, 2026.The first tranche with 3,824,233 new shares at a price of NOK 5.83 per share for gross proceeds of NOK 2,2295,278.39 and it is getting closed on the same day. The second tranche with 11,613,159.795883 at a price of NOK 5.83 per share for gross proceeds of NOK 67,704,721.609998. The first tranche has been approved by the board of directors and an extraordinary general meeting will be held on or about March 27, 2026 to seek the necessary approval for the second tranche.Reported Earnings • Mar 05Full year 2025 earnings released: US$0.26 loss per share (vs US$3.49 loss in FY 2024)Full year 2025 results: US$0.26 loss per share (improved from US$3.49 loss in FY 2024). Net loss: US$10.0m (loss narrowed 31% from FY 2024).お知らせ • Jan 02IDEX Biometrics ASA, Annual General Meeting, May 21, 2026IDEX Biometrics ASA, Annual General Meeting, May 21, 2026.お知らせ • Dec 31+ 3 more updatesIDEX Biometrics ASA to Report First Half, 2026 Results on Aug 20, 2026IDEX Biometrics ASA announced that they will report first half, 2026 results on Aug 20, 2026New Risk • Dec 23New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Norwegian stocks, typically moving 13% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (13% average weekly change). Shareholders have been substantially diluted in the past year (over 5x increase in shares outstanding). Revenue is less than US$1m (US$209k revenue). Minor Risk Market cap is less than US$100m (kr362.3m market cap, or US$36.0m).お知らせ • Dec 05+ 1 more updateIDEX Biometrics ASA has completed a Follow-on Equity Offering in the amount of NOK 21.999999 million.IDEX Biometrics ASA has completed a Follow-on Equity Offering in the amount of NOK 21.999999 million. Security Name: Shares Security Type: Common Stock Securities Offered: 5,690,970 Price\Range: NOK 3 Security Name: Shares Security Type: Common Stock Securities Offered: 1,642,363 Price\Range: NOK 3 Transaction Features: Rule 144A; Subsequent Direct ListingReported Earnings • Nov 15Third quarter 2025 earnings released: US$0.02 loss per share (vs US$0.43 profit in 3Q 2024)Third quarter 2025 results: US$0.02 loss per share (down from US$0.43 profit in 3Q 2024). Net loss: US$992.0k (down 173% from profit in 3Q 2024).お知らせ • Sep 27Reserve Bank of India Approves Biometric Payment Authentication TechnologyReserve Bank of India (RBI) has approved biometric authentication technology for digital payments, including IDEX's fingerprint payment solutions, through new authentication mechanisms for digital payment transactions directions effective April 2026. The RBI mandate specifically endorses fingerprint biometric authentication as an approved method for India's digital payment ecosystem, moving beyond traditional SMS-based one-time passwords. This regulatory approval validates IDEX's strategic positioning in the Indian market. The IDEX Pay solution performs biometric authentication directly on the payment card without requiring infrastructure changes to existing merchant terminals. The technology ensures biometric data remains encrypted and stored exclusively on the card, addressing the RBI's enhanced security requirements while maintaining user privacy.お知らせ • Sep 12IDEX Biometrics ASA Launches New Product Portfolio for Payment and Access SolutionsIDEX Biometrics ASA announced the launch of its new product portfolio for payment and access solutions, accompanied by a redesigned website showcasing the company's advanced biometric authentication offerings. This launch marks a key milestone in the company's strategic transformation and delivery on previously communicated commitments.Reported Earnings • Aug 27Second quarter 2025 earnings released: US$0.07 loss per share (vs US$2.29 loss in 2Q 2024)Second quarter 2025 results: US$0.07 loss per share (improved from US$2.29 loss in 2Q 2024). Net loss: US$2.07m (loss narrowed 69% from 2Q 2024).お知らせ • Jul 22IDEX Biometrics ASA has completed a Follow-on Equity Offering in the amount of NOK 30 million.IDEX Biometrics ASA has completed a Follow-on Equity Offering in the amount of NOK 30 million. Security Name: Shares Security Type: Common Stock Securities Offered: 4,731,594 Price\Range: NOK 3.3 Discount Per Security: NOK 0.165 Security Name: Shares Security Type: Common Stock Securities Offered: 4,359,315 Price\Range: NOK 3.3 Discount Per Security: NOK 0.165 Transaction Features: Subsequent Direct Listingお知らせ • Jun 30IDEX Biometrics ASA Announces Chief Financial Officer Changes, Effective 30 June 2025IDEX Biometrics ASA announced that Kristian Flaten, Chief Financial Officer (CFO), has handed in his resignation as CFO to pursue other opportunities. The resignation is effective on 30 June 2025. Anders Storbråten, existing Chief Executive Officer, will also assume the role as Chief Financial Officer, as of the effective date of Kristian's resignation. Kristian will be available to support the Company in a transition period to secure a smooth handover of the CFO functions to Anders.お知らせ • Jun 07IDEX Biometrics ASA has completed a Follow-on Equity Offering in the amount of NOK 6 million.IDEX Biometrics ASA has completed a Follow-on Equity Offering in the amount of NOK 6 million. Security Name: Shares Security Type: Common Stock Securities Offered: 600,000,000 Price\Range: NOK 0.01 Transaction Features: Rights Offeringお知らせ • May 21IDEX Biometrics ASA Approves Board and Committee ChangesIDEX Biometrics ASA initiated a restructuring of its organization in 2024 to align with business opportunities and reduce costs. The company is consolidating development and business operations primarily in the UK and the EU/EEA. During 2025, the restructuring continued with further cost reductions and changes to the commercial strategy, with new management in place. The Nomination Committee of IDEX Biometrics ASA proposes that Morten Opstad, Annika Olsson, and Adriana Saitta, all current board members and European residents and nationals, form the new board of directors, with Morten Opstad serving as the Chair. The proposal is that they continue for a new term of two years. The Nomination Committee proposes that Mr. Morten Opstad is elected for a new two-year term in the capacity as Chair, and Ms. Annika Olsson and Ms. Adriana Saitta are also elected for a new two-year term as board members. The Nomination Committee's chair, Mr. Robert N. Keith, and member Mr. Harald Voigt were elected for a 2-year term at the 2023 AGM and are now standing for election. Mr. Robert N. Keith is willing to continue to serve for a new two-year period. Mr. Harald Voigt is willing to continue to serve for a new one-year term. Member of the Nomination Committee, Mr. Håvard Nilsson, was elected for a two-year term at the annual general meeting in 2024. The Nomination Committee emphasizes that the composition of the Nomination Committee should be subject to review each year, regardless of the term of election. The Nomination Committee proposes that Mr. Håvard Nilsson will continue for the second year of his term at the Nomination Committee. Mr. Robert N. Keith, chair of the Nomination Committee, is elected as chair of the Nomination Committee for a new period of two years. Mr. Harald Voigt is elected as a member of the Nomination Committee for a one-year term.お知らせ • May 08IDEX Biometrics ASA to Report Q3, 2025 Results on Nov 13, 2025IDEX Biometrics ASA announced that they will report Q3, 2025 results on Nov 13, 2025お知らせ • Mar 11+ 1 more updateIDEX Biometrics ASA has filed a Follow-on Equity Offering in the amount of NOK 6 million.IDEX Biometrics ASA has filed a Follow-on Equity Offering in the amount of NOK 6 million. Security Name: Shares Security Type: Common Stock Securities Offered: 600,000,000 Price\Range: NOK 0.01 Transaction Features: Rights Offeringお知らせ • Jan 02+ 1 more updateIDEX Biometrics ASA, Annual General Meeting, May 21, 2025IDEX Biometrics ASA, Annual General Meeting, May 21, 2025.お知らせ • Jan 01+ 3 more updatesIDEX Biometrics ASA to Report Q4, 2025 Results on Feb 26, 2026IDEX Biometrics ASA announced that they will report Q4, 2025 results on Feb 26, 2026お知らせ • Oct 29IDEX Biometrics ASA Announces Chief Financial Officer ChangesIDEX Biometricshas appointed Kristian Flaten as Chief Financial Officer, effective November 1, 2024. Kristian Flaten brings over 25 years of financial leadership and experience with international business and financing, including from Asian growth markets, a strong focus for IDEX Biometrics. He has a proven track record in corporate finance, debt financing and business development in growth companies. Kristian has a background as CFO with Quantafuel ASA, recycling plastic waste, and as VP Corporate Finance with BW Offshore, oilfield services. Additionally, he has experience from the financial sector with Export Finance Norway and Handelsbanken. Kristian holds a Master of Science from NHH (Norwegian School of Economics), with majors in Finance and Strategy. He will be based at IDEX Biometrics headquarters in Oslo. Kristian Flaten is succeeding John Kurtzweil, who will continue to support the company in an advisory role.お知らせ • Oct 23IDEX Biometrics ASA to Report Q3, 2024 Results on Oct 29, 2024IDEX Biometrics ASA announced that they will report Q3, 2024 results on Oct 29, 2024お知らせ • Aug 28IDEX Biometrics ASA Introduces Biometric Payment Cards in IndiaIDEX Biometrics is bringing biometric authentication onto payment cards for the Indian market, together with a worldwide leader in payment services. India boasts more than 1 billion payment cards in circulation and has been a frontrunner in biometrics for many years. Live user experience and technology testing for the IDEX Pay biometric payment cards has been conducted with Indian payment service partner, giving excellent results, and proving that biometric payment cards can be deployed in a seamless and secure manner throughout India. Newly published research indicates that more than 90% of affluent consumers in India want biometric payment cards. The Reserve Bank of India (RBI) is driving out secure digital payments and is in consultation with Indian banks to mandate alternative multi-factor authentication methods for digital payment transactions. This includes biometric authentication and specifically fingerprints. The payment landscape in India is set to change. With an opportunity to grow contactless payments from current low adoption levels of 16%, the biometric card represents a new secure and convenient payment solution for India. The biometric authentication is performed directly on the payment card, no change to existing payment terminals and infrastructure is needed. Equally important, the IDEX Pay technology ensures cardholder's biometric data never leaves the card, confirming highest level of security and privacy for the consumer.お知らせ • Aug 22IDEX Biometrics ASA Announces Chief Executive Officer ChangesIDEX Biometrics ASA has appointed Catharina Eklof as the new Chief Executive Officer, effective as of 19 August 2024. Catharina Eklof has for the last three years served as Chief Commercial Officer for IDEX Biometrics, and has been instrumental in the transformation from a component provider to a full biometric solution company. Catharina brings global experience in business transformation and has been driving profitable growth initiatives and led commercialization of new technology solutions across industry leading global companies as Mastercard and Securitas. The company thank Vince Graziani for his contributions to the company through challenging times. Vince will continue to support the company in an advisory role.お知らせ • Aug 15+ 1 more updateIDEX Biometrics ASA has withdrawn its Follow-on Equity Offering in the amount of NOK 13.2 million.IDEX Biometrics ASA has withdrawn its Follow-on Equity Offering in the amount of NOK 13.2 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 8,000,000 Price\Range: NOK 1.65 Transaction Features: Rights Offeringお知らせ • May 18IDEX Biometrics ASA Appoints Morten Opstad as ChairIDEX Biometrics ASA at its annual general meeting on 16 May 2024 elected Morten Opstad as Chair.お知らせ • May 17+ 1 more updateIDEX Biometrics ASA has completed a Follow-on Equity Offering in the amount of NOK 55 million.IDEX Biometrics ASA has completed a Follow-on Equity Offering in the amount of NOK 55 million. Security Name: Shares Security Type: Common Stock Securities Offered: 28,012,655 Price\Range: NOK 1.65 Security Name: Shares Security Type: Common Stock Securities Offered: 5,320,678 Price\Range: NOK 1.65 Transaction Features: Subsequent Direct Listingお知らせ • Dec 19+ 5 more updatesIDEX Biometrics ASA, Annual General Meeting, May 16, 2024IDEX Biometrics ASA, Annual General Meeting, May 16, 2024.お知らせ • Nov 17+ 1 more updateIDEX Biometrics ASA has completed a Follow-on Equity Offering in the amount of NOK 35 million.IDEX Biometrics ASA has completed a Follow-on Equity Offering in the amount of NOK 35 million. Security Name: Shares Security Type: Common Stock Securities Offered: 78,651,685 Price\Range: NOK 0.445 Transaction Features: Subsequent Direct Listingお知らせ • Nov 08IDEX Biometrics ASA announced that it expects to receive NOK 100 million in fundingIDEX Biometrics ASA announced that it has entered into a non-binding term sheet to issue senior convertible bond for the gross proceeds of NOK 100 million on November 7, 2023. The bonds will have a coupon rate of 6% per annum. The convertible bond will be issued at a price of 92% of the principal amount, and will be amortized over 3,5 years through instalment every 2 months over the period. The instalment periods may be altered during the amortizing period. Conversion price will be at a premium to the stock price at closing of the final agreements and any repayments by issuance of shares will be at a discount to market price at each instalment. The transaction subject to approval of the formal agreements and shareholder approval.お知らせ • Sep 25IDEX Biometrics ASA Announces Chief Financial Officer ChangesIDEX Biometrics ASA has appointed John T. Kurtzweil as Chief Financial Officer effective September 25, 2023. Mr. Kurtzweil is a highly accomplished financial executive. He joins IDEX Biometrics after having served as CFO at Metabolon, where he was pivotal in revitalizing the company. Prior to Metabolon, he has served as CFO for CREE, Cirrus Logic and ON Semiconductor where he had key roles in finance operations at large, and leading strategic planning as well as mergers and acquisitions, growing shareholder value. Mr. Kurtzweil succeeds Eileen Wynne who has been Interim CFO in IDEX Biometrics since August 2022. Ms. Wynne will continue as a consultant during a transition period.お知らせ • Sep 01IDEX Biometrics Payment Card Solution Fully Certified by MastercardIDEX Biometrics has successfully completed the full Mastercard certification and received Conformity Compliance Statement (CCS) for its IDEX Biometrics Payment Card solution. The complete and certified biometric card solution includes the IDEX biometric sensor, a Linxens EMV module including Infineon's SLC38B secure element, card inlay with antenna, and the IDEX card operating system with payment applets. Biometric payment cards built on the IDEX Biometrics payment card solution will provide seamless payment experiences for consumers around the world. The IDEX Biometrics payment Card solution has successfully completed Mastercard's Compliance Assessment and Security Testing (CAST). This is the final Mastercard certification step and follows the previously announced FTAS certification of the sensor performance. Smartcard manufacturers can now fully leverage this certification for their Letters of Approval (LoA) without having to complete compliance tests on their own, significantly reducing development cost and time to market. More than 15 global and regional card manufacturers and resellers have already selected the IDEX Biometrics certified payment card solution, as they respond to the increasing demand from banks and fintechs for biometric payment cards. Mastercard Compliance Assessment and Security Testing (Cast) and Interface and Application Testing (IAT). Testing performed by independent certified test labs accredited by EMVCo and qualified by Mastercard2 EMV stands for Europay, Mastercard and Visa.お知らせ • Jul 23IDEX Biometrics Announces Intention to Voluntary Delist of American Depositary Shares from the Nasdaq Capital MarketIDEX Biometrics ASA announced it has given formal notice to the Nasdaq Stock Market of the Company’s intention to voluntary delist American Depositary Shares (“ADSs’) representing its ordinary shares, which is anticipated to be effective prior to the opening of trading on August 10, 2023. Each ADS represents 75 ordinary shares of the Company. Ordinary shares of IDEX Biometrics have been listed on the Oslo Bors since May 11, 2015, under the ticker IDEX.OL. The ordinary shares trade in Norwegian krone. The Company subsequently listed the ADSs on The Nasdaq Capital Market in March 2021 under the ticker IDBA. The ADSs trade in U.S. dollars. The ADS delisting will have no impact on the Company’s accounting standards, and IDEX intends to continue its disclosures in compliance with applicable Norwegian financial market regulations. IDEX intends to file a Form 25 and, thereafter, a Form 15F with the Securities and Exchange Commission (“SEC”) within the coming weeks to initiate the removal of the ADS listing and deregistration of the ADSs and underlying ordinary shares under the Securities Exchange Act of 1934, as amended (“Exchange Act”), and expects the ADS delisting to become effective on or around August 10, 2023, at which time the Company’s ADSs will no longer trade on The Nasdaq Capital Market and the IDEX reporting obligations with the SEC will be suspended. The Company expects that the deregistration of the ADSs and the underlying ordinary shares under the Exchange Act will become effective on or around October 29, 2023.お知らせ • May 26IDEX Biometrics ASA announced that it expects to receive NOK 150 million in fundingIDEX Biometrics ASA announced a private placement to raise gross proceeds of NOK 150 million in an equity round of funding on May 24, 2023. The transaction will include participation from Norwegian and international investors. The private placement will be divided into two tranches. Tranche 1 will consist of 116,897,492 offer shares. Tranche 2 will consist of up to the number of offer shares that, together with the tranche 1 offer shares, is necessary to raise gross proceeds of NOK 150 million. The allocations of offer shares to investors are expected to be split between Tranche 1 and Tranche 2 on a pro rata basis. The investors are subject to applicable exemptions from relevant prospectus, filing or other registration requirements. The minimum application and allocation amount in the private placement will be the NOK equivalent of €100,000. The company will announce the final number of offer shares placed and the final offer price in a stock exchange announcement expected to be published before the opening of trading on the Oslo Stock Exchange tomorrow, 25 May 2023. The completion of Tranche 1 is subject to approval by the board. The completion of tranche 2 will be subject to approval by an extraordinary general meeting of the company expected to be held on or about 16 June 2023. The settlement of the Tranche 1 offer shares is expected to take place on a delivery versus payment basis on or about 30 May 2023. Settlement of the Tranche 2 offer shares is expected to take place on a delivery versus payment basis on or about 20 June 2023.お知らせ • May 24IDEX Biometrics ASA Approves the Election of Adriana Saitta as Board MemberIDEX Biometrics ASA at its annual general meeting held on 23 May 2023 approved the election of Adriana Saitta as board member.お知らせ • May 12IDEX Biometrics Launches a Complete Biometric Payment Card Solution Leveraging Products and Technologies from STMicroelectronicsIDEX Biometrics has developed an advanced solution for biometric smart cards, leveraging products and technologies from STMicroelectronics. The solution combines the biometric system from IDEX Biometrics with the latest Secure Element from ST and is fully integrated with ST's STPay-Topaz-Bio Operating System and payment applets. This high-performance solution includes the ST31N600 secure microcontroller with biometric features, packaged in a single-chip EMV module, and includes a cost- effective enrollment solution. Bringing these innovations to market enables cost efficiencies for manufacturers and significantly improves the user experience. The solution is now completely tested and validated, demonstrating market-leading biometric performance and transaction latency. This new IDEX Biometrics smart card solution is targeted for deployment with banks and issuers in the first half of 2024.Reported Earnings • May 02Full year 2022 earnings: EPS and revenues exceed analyst expectationsFull year 2022 results: US$0.032 loss per share. Revenue: US$4.09m (up 44% from FY 2021). Net loss: US$32.7m (flat on FY 2021). Revenue exceeded analyst estimates by 5.1%. Earnings per share (EPS) also surpassed analyst estimates by 3.7%. Revenue is forecast to grow 105% p.a. on average during the next 2 years, compared to a 18% growth forecast for the Electronic industry in Norway.Reported Earnings • Feb 22Full year 2022 earnings: EPS and revenues exceed analyst expectationsFull year 2022 results: US$0.03 loss per share. Revenue: US$4.09m (up 44% from FY 2021). Net loss: US$32.7m (flat on FY 2021). Revenue exceeded analyst estimates by 5.1%. Earnings per share (EPS) also surpassed analyst estimates by 3.7%.お知らせ • Dec 23+ 3 more updatesIDEX Biometrics ASA to Report Q3, 2023 Results on Nov 09, 2023IDEX Biometrics ASA announced that they will report Q3, 2023 results on Nov 09, 2023Reported Earnings • Nov 16Third quarter 2022 earnings released: US$0.009 loss per share (vs US$0.008 loss in 3Q 2021)Third quarter 2022 results: US$0.009 loss per share (further deteriorated from US$0.008 loss in 3Q 2021). Revenue: US$928.0k (up 27% from 3Q 2021). Net loss: US$9.02m (loss widened 21% from 3Q 2021). Revenue is forecast to grow 200% p.a. on average during the next 2 years, compared to a 34% growth forecast for the Electronic industry in Norway. Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has only increased by 9% per year, which means it is significantly lagging earnings growth.Reported Earnings • Nov 12Third quarter 2022 earnings released: US$0.01 loss per share (vs US$0.008 loss in 3Q 2021)Third quarter 2022 results: US$0.01 loss per share (further deteriorated from US$0.008 loss in 3Q 2021). Revenue: US$928.0k (up 27% from 3Q 2021). Net loss: US$9.02m (loss widened 21% from 3Q 2021). Revenue is forecast to grow 193% p.a. on average during the next 2 years, compared to a 31% growth forecast for the Electronic industry in Norway. Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has only increased by 6% per year, which means it is significantly lagging earnings growth.Breakeven Date Change • Sep 28Forecast to breakeven in 2024The 2 analysts covering IDEX Biometrics expect the company to break even for the first time. New consensus forecast suggests losses will reduce by 65% per year to 2023. The company is expected to make a profit of US$200.0k in 2024. Average annual earnings growth of 84% is required to achieve expected profit on schedule.分析記事 • Sep 11Here's Why IDEX Biometrics (OB:IDEX) Must Use Its Cash WiselyThere's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...Reported Earnings • Aug 12Second quarter 2022 earnings released: US$0.01 loss per share (vs US$0.008 loss in 2Q 2021)Second quarter 2022 results: US$0.01 loss per share (down from US$0.008 loss in 2Q 2021). Revenue: US$1.11m (up 59% from 2Q 2021). Net loss: US$9.24m (loss widened 28% from 2Q 2021). Over the next year, revenue is forecast to grow 573%, compared to a 119% growth forecast for the industry in Norway. Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has fallen by 9% per year, which means it is significantly lagging earnings.Reported Earnings • May 13First quarter 2022 earnings: EPS and revenues miss analyst expectationsFirst quarter 2022 results: US$0.01 loss per share (down from US$0.009 loss in 1Q 2021). Revenue: US$989.0k (up 59% from 1Q 2021). Net loss: US$8.12m (loss widened 7.9% from 1Q 2021). Revenue missed analyst estimates by 36%. Earnings per share (EPS) also missed analyst estimates by 38%. Over the next year, revenue is forecast to grow 474%, compared to a 169% growth forecast for the industry in Norway. Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has fallen by 29% per year, which means it is significantly lagging earnings.Reported Earnings • Feb 28Full year 2021 earnings: EPS in line with analyst expectations despite revenue beatFull year 2021 results: US$0.035 loss per share (vs US$0.035 loss in FY 2020). Net loss: US$32.6m (loss widened 22% from FY 2020). Revenue exceeded analyst estimates by 2.4%. Over the next year, revenue is forecast to grow 483%, compared to a 216% growth forecast for the industry in Norway. Over the last 3 years on average, earnings per share has increased by 20% per year but the company’s share price has fallen by 21% per year, which means it is significantly lagging earnings.Breakeven Date Change • Jan 01Forecast to breakeven in 2024The 2 analysts covering IDEX Biometrics expect the company to break even for the first time. New consensus forecast suggests the company will make a profit of US$200.0k in 2024. Average annual earnings growth of 55% is required to achieve expected profit on schedule.Reported Earnings • Nov 06Third quarter 2021 earnings released: US$0.01 loss per share (vs US$0.009 loss in 3Q 2020)The company reported a solid third quarter result with improved revenues and control over costs, although losses increased. Third quarter 2021 results: Revenue: US$732.0k (up 195% from 3Q 2020). Net loss: US$7.47m (loss widened 10.0% from 3Q 2020). Over the last 3 years on average, earnings per share has increased by 21% per year but the company’s share price has fallen by 13% per year, which means it is significantly lagging earnings.分析記事 • Oct 23We Think IDEX Biometrics (OB:IDEX) Needs To Drive Business Growth CarefullyJust because a business does not make any money, does not mean that the stock will go down. For example, biotech and...Reported Earnings • Aug 13Second quarter 2021 earnings released: US$0.01 loss per share (vs US$0.009 loss in 2Q 2020)The company reported a solid second quarter result with improved revenues and control over costs, although losses increased. Second quarter 2021 results: Revenue: US$697.0k (up 368% from 2Q 2020). Net loss: US$7.24m (loss widened 13% from 2Q 2020). Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has fallen by 23% per year, which means it is significantly lagging earnings.分析記事 • May 14We Think IDEX Biometrics (OB:IDEX) Needs To Drive Business Growth CarefullyWe can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...Reported Earnings • May 13First quarter 2021 earnings released: US$0.01 loss per share (vs US$0.009 loss in 1Q 2020)First quarter 2021 results: Net loss: US$7.53m (loss widened 19% from 1Q 2020). Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has fallen by 19% per year, which means it is significantly lagging earnings.Executive Departure • May 04Advisor has left the companyOn the 1st of May, Derek D'Antilio's tenure as Advisor ended after less than a year in the role. As of December 2020, Derek personally held 681.93k shares (kr2.0m worth at the time). Derek is the only executive to leave the company over the last 12 months.Reported Earnings • Apr 25Full year 2020 earnings released: US$0.035 loss per share (vs US$0.054 loss in FY 2019)Full year 2020 results: Net loss: US$26.8m (loss narrowed 18% from FY 2019). Over the last 3 years on average, earnings per share has increased by 16% per year but the company’s share price has fallen by 13% per year, which means it is significantly lagging earnings.分析記事 • Mar 03Chief Executive Officer Vincent Graziani Just Bought 19% More Shares In IDEX Biometrics ASA (OB:IDEX)Those following along with IDEX Biometrics ASA ( OB:IDEX ) will no doubt be intrigued by the recent purchase of shares...Recent Insider Transactions • Mar 03Chief Executive Officer recently bought kr37m worth of stockOn the 1st of March, Vincent Graziani bought around 150k shares on-market at roughly kr246 per share. This was the largest purchase by an insider in the last 3 months. Vincent has been a buyer over the last 12 months, purchasing a net total of kr38m worth in shares.分析記事 • Feb 27Did The Underlying Business Drive IDEX Biometrics' (OB:IDEX) Lovely 324% Share Price Gain?For many, the main point of investing in the stock market is to achieve spectacular returns. When an investor finds a...Reported Earnings • Feb 26Full year 2020 earnings released: US$0.03 loss per share (vs US$0.055 loss in FY 2019)Full year 2020 results: Net loss: US$26.8m (loss narrowed 18% from FY 2019). Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has fallen by 17% per year, which means it is significantly lagging earnings.Analyst Estimate Surprise Post Earnings • Feb 26Revenue and earnings miss expectationsRevenue missed analyst estimates by 3.8%. Earnings per share (EPS) also missed analyst estimates by 16%. Over the next year, revenue is forecast to grow 357%, compared to a 235% growth forecast for the Electronic industry in Norway.Is New 90 Day High Low • Feb 22New 90-day high: kr3.33The company is up 70% from its price of kr1.95 on 24 November 2020. The Norwegian market is up 11% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Electronic industry, which is up 27% over the same period.Is New 90 Day High Low • Dec 28New 90-day high: kr3.10The company is up 49% from its price of kr2.08 on 29 September 2020. The Norwegian market is up 12% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Electronic industry, which is up 7.0% over the same period.決済の安定と成長配当データの取得安定した配当: IDEXの 1 株当たり配当が過去に安定していたかどうかを判断するにはデータが不十分です。増加する配当: IDEXの配当金が増加しているかどうかを判断するにはデータが不十分です。配当利回り対市場IDEX Biometrics 配当利回り対市場IDEX 配当利回りは市場と比べてどうか？セグメント配当利回り会社 (IDEX)n/a市場下位25% (NO)3.1%市場トップ25% (NO)7.4%業界平均 (Electronic)1.4%アナリスト予想 (IDEX) (最長3年)n/a注目すべき配当: IDEXは最近配当金を報告していないため、配当金支払者の下位 25% に対して同社の配当利回りを評価することはできません。高配当: IDEXは最近配当金を報告していないため、配当金支払者の上位 25% に対して同社の配当利回りを評価することはできません。株主への利益配当収益カバレッジ: IDEXの 配当性向 を計算して配当金の支払いが利益で賄われているかどうかを判断するにはデータが不十分です。株主配当金キャッシュフローカバレッジ: IDEXが配当金を報告していないため、配当金の持続可能性を計算できません。高配当企業の発掘7D1Y7D1Y7D1YNO 市場の強力な配当支払い企業。View Management企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/08 07:19終値2026/05/08 00:00収益2025/12/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋IDEX Biometrics ASA 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。5 アナリスト機関Hans Rettedal ChristiansenCarnegie Investment Bank ABJonas LisauskasNorne Securities ASAuguste RichardNorthland Capital Markets2 その他のアナリストを表示
お知らせ • Apr 29IDEX Biometrics ASA has filed a Follow-on Equity Offering in the amount of NOK 19.999997 million.IDEX Biometrics ASA has filed a Follow-on Equity Offering in the amount of NOK 19.999997 million. Security Name: Shares Security Type: Common Stock Securities Offered: 2,424,242 Price\Range: NOK 8.25 Transaction Features: Rights Offering
お知らせ • Mar 06IDEX Biometrics ASA announced that it expects to receive NOK 90.000001 million in fundingIDEX Biometrics ASA announced a private placement to issue NOK 90,000,000 to ID centric in two tranches on March 5, 2026.The first tranche with 3,824,233 new shares at a price of NOK 5.83 per share for gross proceeds of NOK 2,2295,278.39 and it is getting closed on the same day. The second tranche with 11,613,159.795883 at a price of NOK 5.83 per share for gross proceeds of NOK 67,704,721.609998. The first tranche has been approved by the board of directors and an extraordinary general meeting will be held on or about March 27, 2026 to seek the necessary approval for the second tranche.
Reported Earnings • Mar 05Full year 2025 earnings released: US$0.26 loss per share (vs US$3.49 loss in FY 2024)Full year 2025 results: US$0.26 loss per share (improved from US$3.49 loss in FY 2024). Net loss: US$10.0m (loss narrowed 31% from FY 2024).
お知らせ • Jan 02IDEX Biometrics ASA, Annual General Meeting, May 21, 2026IDEX Biometrics ASA, Annual General Meeting, May 21, 2026.
お知らせ • Dec 31+ 3 more updatesIDEX Biometrics ASA to Report First Half, 2026 Results on Aug 20, 2026IDEX Biometrics ASA announced that they will report first half, 2026 results on Aug 20, 2026
New Risk • Dec 23New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Norwegian stocks, typically moving 13% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (13% average weekly change). Shareholders have been substantially diluted in the past year (over 5x increase in shares outstanding). Revenue is less than US$1m (US$209k revenue). Minor Risk Market cap is less than US$100m (kr362.3m market cap, or US$36.0m).
お知らせ • Dec 05+ 1 more updateIDEX Biometrics ASA has completed a Follow-on Equity Offering in the amount of NOK 21.999999 million.IDEX Biometrics ASA has completed a Follow-on Equity Offering in the amount of NOK 21.999999 million. Security Name: Shares Security Type: Common Stock Securities Offered: 5,690,970 Price\Range: NOK 3 Security Name: Shares Security Type: Common Stock Securities Offered: 1,642,363 Price\Range: NOK 3 Transaction Features: Rule 144A; Subsequent Direct Listing
Reported Earnings • Nov 15Third quarter 2025 earnings released: US$0.02 loss per share (vs US$0.43 profit in 3Q 2024)Third quarter 2025 results: US$0.02 loss per share (down from US$0.43 profit in 3Q 2024). Net loss: US$992.0k (down 173% from profit in 3Q 2024).
お知らせ • Sep 27Reserve Bank of India Approves Biometric Payment Authentication TechnologyReserve Bank of India (RBI) has approved biometric authentication technology for digital payments, including IDEX's fingerprint payment solutions, through new authentication mechanisms for digital payment transactions directions effective April 2026. The RBI mandate specifically endorses fingerprint biometric authentication as an approved method for India's digital payment ecosystem, moving beyond traditional SMS-based one-time passwords. This regulatory approval validates IDEX's strategic positioning in the Indian market. The IDEX Pay solution performs biometric authentication directly on the payment card without requiring infrastructure changes to existing merchant terminals. The technology ensures biometric data remains encrypted and stored exclusively on the card, addressing the RBI's enhanced security requirements while maintaining user privacy.
お知らせ • Sep 12IDEX Biometrics ASA Launches New Product Portfolio for Payment and Access SolutionsIDEX Biometrics ASA announced the launch of its new product portfolio for payment and access solutions, accompanied by a redesigned website showcasing the company's advanced biometric authentication offerings. This launch marks a key milestone in the company's strategic transformation and delivery on previously communicated commitments.
Reported Earnings • Aug 27Second quarter 2025 earnings released: US$0.07 loss per share (vs US$2.29 loss in 2Q 2024)Second quarter 2025 results: US$0.07 loss per share (improved from US$2.29 loss in 2Q 2024). Net loss: US$2.07m (loss narrowed 69% from 2Q 2024).
お知らせ • Jul 22IDEX Biometrics ASA has completed a Follow-on Equity Offering in the amount of NOK 30 million.IDEX Biometrics ASA has completed a Follow-on Equity Offering in the amount of NOK 30 million. Security Name: Shares Security Type: Common Stock Securities Offered: 4,731,594 Price\Range: NOK 3.3 Discount Per Security: NOK 0.165 Security Name: Shares Security Type: Common Stock Securities Offered: 4,359,315 Price\Range: NOK 3.3 Discount Per Security: NOK 0.165 Transaction Features: Subsequent Direct Listing
お知らせ • Jun 30IDEX Biometrics ASA Announces Chief Financial Officer Changes, Effective 30 June 2025IDEX Biometrics ASA announced that Kristian Flaten, Chief Financial Officer (CFO), has handed in his resignation as CFO to pursue other opportunities. The resignation is effective on 30 June 2025. Anders Storbråten, existing Chief Executive Officer, will also assume the role as Chief Financial Officer, as of the effective date of Kristian's resignation. Kristian will be available to support the Company in a transition period to secure a smooth handover of the CFO functions to Anders.
お知らせ • Jun 07IDEX Biometrics ASA has completed a Follow-on Equity Offering in the amount of NOK 6 million.IDEX Biometrics ASA has completed a Follow-on Equity Offering in the amount of NOK 6 million. Security Name: Shares Security Type: Common Stock Securities Offered: 600,000,000 Price\Range: NOK 0.01 Transaction Features: Rights Offering
お知らせ • May 21IDEX Biometrics ASA Approves Board and Committee ChangesIDEX Biometrics ASA initiated a restructuring of its organization in 2024 to align with business opportunities and reduce costs. The company is consolidating development and business operations primarily in the UK and the EU/EEA. During 2025, the restructuring continued with further cost reductions and changes to the commercial strategy, with new management in place. The Nomination Committee of IDEX Biometrics ASA proposes that Morten Opstad, Annika Olsson, and Adriana Saitta, all current board members and European residents and nationals, form the new board of directors, with Morten Opstad serving as the Chair. The proposal is that they continue for a new term of two years. The Nomination Committee proposes that Mr. Morten Opstad is elected for a new two-year term in the capacity as Chair, and Ms. Annika Olsson and Ms. Adriana Saitta are also elected for a new two-year term as board members. The Nomination Committee's chair, Mr. Robert N. Keith, and member Mr. Harald Voigt were elected for a 2-year term at the 2023 AGM and are now standing for election. Mr. Robert N. Keith is willing to continue to serve for a new two-year period. Mr. Harald Voigt is willing to continue to serve for a new one-year term. Member of the Nomination Committee, Mr. Håvard Nilsson, was elected for a two-year term at the annual general meeting in 2024. The Nomination Committee emphasizes that the composition of the Nomination Committee should be subject to review each year, regardless of the term of election. The Nomination Committee proposes that Mr. Håvard Nilsson will continue for the second year of his term at the Nomination Committee. Mr. Robert N. Keith, chair of the Nomination Committee, is elected as chair of the Nomination Committee for a new period of two years. Mr. Harald Voigt is elected as a member of the Nomination Committee for a one-year term.
お知らせ • May 08IDEX Biometrics ASA to Report Q3, 2025 Results on Nov 13, 2025IDEX Biometrics ASA announced that they will report Q3, 2025 results on Nov 13, 2025
お知らせ • Mar 11+ 1 more updateIDEX Biometrics ASA has filed a Follow-on Equity Offering in the amount of NOK 6 million.IDEX Biometrics ASA has filed a Follow-on Equity Offering in the amount of NOK 6 million. Security Name: Shares Security Type: Common Stock Securities Offered: 600,000,000 Price\Range: NOK 0.01 Transaction Features: Rights Offering
お知らせ • Jan 02+ 1 more updateIDEX Biometrics ASA, Annual General Meeting, May 21, 2025IDEX Biometrics ASA, Annual General Meeting, May 21, 2025.
お知らせ • Jan 01+ 3 more updatesIDEX Biometrics ASA to Report Q4, 2025 Results on Feb 26, 2026IDEX Biometrics ASA announced that they will report Q4, 2025 results on Feb 26, 2026
お知らせ • Oct 29IDEX Biometrics ASA Announces Chief Financial Officer ChangesIDEX Biometricshas appointed Kristian Flaten as Chief Financial Officer, effective November 1, 2024. Kristian Flaten brings over 25 years of financial leadership and experience with international business and financing, including from Asian growth markets, a strong focus for IDEX Biometrics. He has a proven track record in corporate finance, debt financing and business development in growth companies. Kristian has a background as CFO with Quantafuel ASA, recycling plastic waste, and as VP Corporate Finance with BW Offshore, oilfield services. Additionally, he has experience from the financial sector with Export Finance Norway and Handelsbanken. Kristian holds a Master of Science from NHH (Norwegian School of Economics), with majors in Finance and Strategy. He will be based at IDEX Biometrics headquarters in Oslo. Kristian Flaten is succeeding John Kurtzweil, who will continue to support the company in an advisory role.
お知らせ • Oct 23IDEX Biometrics ASA to Report Q3, 2024 Results on Oct 29, 2024IDEX Biometrics ASA announced that they will report Q3, 2024 results on Oct 29, 2024
お知らせ • Aug 28IDEX Biometrics ASA Introduces Biometric Payment Cards in IndiaIDEX Biometrics is bringing biometric authentication onto payment cards for the Indian market, together with a worldwide leader in payment services. India boasts more than 1 billion payment cards in circulation and has been a frontrunner in biometrics for many years. Live user experience and technology testing for the IDEX Pay biometric payment cards has been conducted with Indian payment service partner, giving excellent results, and proving that biometric payment cards can be deployed in a seamless and secure manner throughout India. Newly published research indicates that more than 90% of affluent consumers in India want biometric payment cards. The Reserve Bank of India (RBI) is driving out secure digital payments and is in consultation with Indian banks to mandate alternative multi-factor authentication methods for digital payment transactions. This includes biometric authentication and specifically fingerprints. The payment landscape in India is set to change. With an opportunity to grow contactless payments from current low adoption levels of 16%, the biometric card represents a new secure and convenient payment solution for India. The biometric authentication is performed directly on the payment card, no change to existing payment terminals and infrastructure is needed. Equally important, the IDEX Pay technology ensures cardholder's biometric data never leaves the card, confirming highest level of security and privacy for the consumer.
お知らせ • Aug 22IDEX Biometrics ASA Announces Chief Executive Officer ChangesIDEX Biometrics ASA has appointed Catharina Eklof as the new Chief Executive Officer, effective as of 19 August 2024. Catharina Eklof has for the last three years served as Chief Commercial Officer for IDEX Biometrics, and has been instrumental in the transformation from a component provider to a full biometric solution company. Catharina brings global experience in business transformation and has been driving profitable growth initiatives and led commercialization of new technology solutions across industry leading global companies as Mastercard and Securitas. The company thank Vince Graziani for his contributions to the company through challenging times. Vince will continue to support the company in an advisory role.
お知らせ • Aug 15+ 1 more updateIDEX Biometrics ASA has withdrawn its Follow-on Equity Offering in the amount of NOK 13.2 million.IDEX Biometrics ASA has withdrawn its Follow-on Equity Offering in the amount of NOK 13.2 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 8,000,000 Price\Range: NOK 1.65 Transaction Features: Rights Offering
お知らせ • May 18IDEX Biometrics ASA Appoints Morten Opstad as ChairIDEX Biometrics ASA at its annual general meeting on 16 May 2024 elected Morten Opstad as Chair.
お知らせ • May 17+ 1 more updateIDEX Biometrics ASA has completed a Follow-on Equity Offering in the amount of NOK 55 million.IDEX Biometrics ASA has completed a Follow-on Equity Offering in the amount of NOK 55 million. Security Name: Shares Security Type: Common Stock Securities Offered: 28,012,655 Price\Range: NOK 1.65 Security Name: Shares Security Type: Common Stock Securities Offered: 5,320,678 Price\Range: NOK 1.65 Transaction Features: Subsequent Direct Listing
お知らせ • Dec 19+ 5 more updatesIDEX Biometrics ASA, Annual General Meeting, May 16, 2024IDEX Biometrics ASA, Annual General Meeting, May 16, 2024.
お知らせ • Nov 17+ 1 more updateIDEX Biometrics ASA has completed a Follow-on Equity Offering in the amount of NOK 35 million.IDEX Biometrics ASA has completed a Follow-on Equity Offering in the amount of NOK 35 million. Security Name: Shares Security Type: Common Stock Securities Offered: 78,651,685 Price\Range: NOK 0.445 Transaction Features: Subsequent Direct Listing
お知らせ • Nov 08IDEX Biometrics ASA announced that it expects to receive NOK 100 million in fundingIDEX Biometrics ASA announced that it has entered into a non-binding term sheet to issue senior convertible bond for the gross proceeds of NOK 100 million on November 7, 2023. The bonds will have a coupon rate of 6% per annum. The convertible bond will be issued at a price of 92% of the principal amount, and will be amortized over 3,5 years through instalment every 2 months over the period. The instalment periods may be altered during the amortizing period. Conversion price will be at a premium to the stock price at closing of the final agreements and any repayments by issuance of shares will be at a discount to market price at each instalment. The transaction subject to approval of the formal agreements and shareholder approval.
お知らせ • Sep 25IDEX Biometrics ASA Announces Chief Financial Officer ChangesIDEX Biometrics ASA has appointed John T. Kurtzweil as Chief Financial Officer effective September 25, 2023. Mr. Kurtzweil is a highly accomplished financial executive. He joins IDEX Biometrics after having served as CFO at Metabolon, where he was pivotal in revitalizing the company. Prior to Metabolon, he has served as CFO for CREE, Cirrus Logic and ON Semiconductor where he had key roles in finance operations at large, and leading strategic planning as well as mergers and acquisitions, growing shareholder value. Mr. Kurtzweil succeeds Eileen Wynne who has been Interim CFO in IDEX Biometrics since August 2022. Ms. Wynne will continue as a consultant during a transition period.
お知らせ • Sep 01IDEX Biometrics Payment Card Solution Fully Certified by MastercardIDEX Biometrics has successfully completed the full Mastercard certification and received Conformity Compliance Statement (CCS) for its IDEX Biometrics Payment Card solution. The complete and certified biometric card solution includes the IDEX biometric sensor, a Linxens EMV module including Infineon's SLC38B secure element, card inlay with antenna, and the IDEX card operating system with payment applets. Biometric payment cards built on the IDEX Biometrics payment card solution will provide seamless payment experiences for consumers around the world. The IDEX Biometrics payment Card solution has successfully completed Mastercard's Compliance Assessment and Security Testing (CAST). This is the final Mastercard certification step and follows the previously announced FTAS certification of the sensor performance. Smartcard manufacturers can now fully leverage this certification for their Letters of Approval (LoA) without having to complete compliance tests on their own, significantly reducing development cost and time to market. More than 15 global and regional card manufacturers and resellers have already selected the IDEX Biometrics certified payment card solution, as they respond to the increasing demand from banks and fintechs for biometric payment cards. Mastercard Compliance Assessment and Security Testing (Cast) and Interface and Application Testing (IAT). Testing performed by independent certified test labs accredited by EMVCo and qualified by Mastercard2 EMV stands for Europay, Mastercard and Visa.
お知らせ • Jul 23IDEX Biometrics Announces Intention to Voluntary Delist of American Depositary Shares from the Nasdaq Capital MarketIDEX Biometrics ASA announced it has given formal notice to the Nasdaq Stock Market of the Company’s intention to voluntary delist American Depositary Shares (“ADSs’) representing its ordinary shares, which is anticipated to be effective prior to the opening of trading on August 10, 2023. Each ADS represents 75 ordinary shares of the Company. Ordinary shares of IDEX Biometrics have been listed on the Oslo Bors since May 11, 2015, under the ticker IDEX.OL. The ordinary shares trade in Norwegian krone. The Company subsequently listed the ADSs on The Nasdaq Capital Market in March 2021 under the ticker IDBA. The ADSs trade in U.S. dollars. The ADS delisting will have no impact on the Company’s accounting standards, and IDEX intends to continue its disclosures in compliance with applicable Norwegian financial market regulations. IDEX intends to file a Form 25 and, thereafter, a Form 15F with the Securities and Exchange Commission (“SEC”) within the coming weeks to initiate the removal of the ADS listing and deregistration of the ADSs and underlying ordinary shares under the Securities Exchange Act of 1934, as amended (“Exchange Act”), and expects the ADS delisting to become effective on or around August 10, 2023, at which time the Company’s ADSs will no longer trade on The Nasdaq Capital Market and the IDEX reporting obligations with the SEC will be suspended. The Company expects that the deregistration of the ADSs and the underlying ordinary shares under the Exchange Act will become effective on or around October 29, 2023.
お知らせ • May 26IDEX Biometrics ASA announced that it expects to receive NOK 150 million in fundingIDEX Biometrics ASA announced a private placement to raise gross proceeds of NOK 150 million in an equity round of funding on May 24, 2023. The transaction will include participation from Norwegian and international investors. The private placement will be divided into two tranches. Tranche 1 will consist of 116,897,492 offer shares. Tranche 2 will consist of up to the number of offer shares that, together with the tranche 1 offer shares, is necessary to raise gross proceeds of NOK 150 million. The allocations of offer shares to investors are expected to be split between Tranche 1 and Tranche 2 on a pro rata basis. The investors are subject to applicable exemptions from relevant prospectus, filing or other registration requirements. The minimum application and allocation amount in the private placement will be the NOK equivalent of €100,000. The company will announce the final number of offer shares placed and the final offer price in a stock exchange announcement expected to be published before the opening of trading on the Oslo Stock Exchange tomorrow, 25 May 2023. The completion of Tranche 1 is subject to approval by the board. The completion of tranche 2 will be subject to approval by an extraordinary general meeting of the company expected to be held on or about 16 June 2023. The settlement of the Tranche 1 offer shares is expected to take place on a delivery versus payment basis on or about 30 May 2023. Settlement of the Tranche 2 offer shares is expected to take place on a delivery versus payment basis on or about 20 June 2023.
お知らせ • May 24IDEX Biometrics ASA Approves the Election of Adriana Saitta as Board MemberIDEX Biometrics ASA at its annual general meeting held on 23 May 2023 approved the election of Adriana Saitta as board member.
お知らせ • May 12IDEX Biometrics Launches a Complete Biometric Payment Card Solution Leveraging Products and Technologies from STMicroelectronicsIDEX Biometrics has developed an advanced solution for biometric smart cards, leveraging products and technologies from STMicroelectronics. The solution combines the biometric system from IDEX Biometrics with the latest Secure Element from ST and is fully integrated with ST's STPay-Topaz-Bio Operating System and payment applets. This high-performance solution includes the ST31N600 secure microcontroller with biometric features, packaged in a single-chip EMV module, and includes a cost- effective enrollment solution. Bringing these innovations to market enables cost efficiencies for manufacturers and significantly improves the user experience. The solution is now completely tested and validated, demonstrating market-leading biometric performance and transaction latency. This new IDEX Biometrics smart card solution is targeted for deployment with banks and issuers in the first half of 2024.
Reported Earnings • May 02Full year 2022 earnings: EPS and revenues exceed analyst expectationsFull year 2022 results: US$0.032 loss per share. Revenue: US$4.09m (up 44% from FY 2021). Net loss: US$32.7m (flat on FY 2021). Revenue exceeded analyst estimates by 5.1%. Earnings per share (EPS) also surpassed analyst estimates by 3.7%. Revenue is forecast to grow 105% p.a. on average during the next 2 years, compared to a 18% growth forecast for the Electronic industry in Norway.
Reported Earnings • Feb 22Full year 2022 earnings: EPS and revenues exceed analyst expectationsFull year 2022 results: US$0.03 loss per share. Revenue: US$4.09m (up 44% from FY 2021). Net loss: US$32.7m (flat on FY 2021). Revenue exceeded analyst estimates by 5.1%. Earnings per share (EPS) also surpassed analyst estimates by 3.7%.
お知らせ • Dec 23+ 3 more updatesIDEX Biometrics ASA to Report Q3, 2023 Results on Nov 09, 2023IDEX Biometrics ASA announced that they will report Q3, 2023 results on Nov 09, 2023
Reported Earnings • Nov 16Third quarter 2022 earnings released: US$0.009 loss per share (vs US$0.008 loss in 3Q 2021)Third quarter 2022 results: US$0.009 loss per share (further deteriorated from US$0.008 loss in 3Q 2021). Revenue: US$928.0k (up 27% from 3Q 2021). Net loss: US$9.02m (loss widened 21% from 3Q 2021). Revenue is forecast to grow 200% p.a. on average during the next 2 years, compared to a 34% growth forecast for the Electronic industry in Norway. Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has only increased by 9% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Nov 12Third quarter 2022 earnings released: US$0.01 loss per share (vs US$0.008 loss in 3Q 2021)Third quarter 2022 results: US$0.01 loss per share (further deteriorated from US$0.008 loss in 3Q 2021). Revenue: US$928.0k (up 27% from 3Q 2021). Net loss: US$9.02m (loss widened 21% from 3Q 2021). Revenue is forecast to grow 193% p.a. on average during the next 2 years, compared to a 31% growth forecast for the Electronic industry in Norway. Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has only increased by 6% per year, which means it is significantly lagging earnings growth.
Breakeven Date Change • Sep 28Forecast to breakeven in 2024The 2 analysts covering IDEX Biometrics expect the company to break even for the first time. New consensus forecast suggests losses will reduce by 65% per year to 2023. The company is expected to make a profit of US$200.0k in 2024. Average annual earnings growth of 84% is required to achieve expected profit on schedule.
分析記事 • Sep 11Here's Why IDEX Biometrics (OB:IDEX) Must Use Its Cash WiselyThere's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...
Reported Earnings • Aug 12Second quarter 2022 earnings released: US$0.01 loss per share (vs US$0.008 loss in 2Q 2021)Second quarter 2022 results: US$0.01 loss per share (down from US$0.008 loss in 2Q 2021). Revenue: US$1.11m (up 59% from 2Q 2021). Net loss: US$9.24m (loss widened 28% from 2Q 2021). Over the next year, revenue is forecast to grow 573%, compared to a 119% growth forecast for the industry in Norway. Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has fallen by 9% per year, which means it is significantly lagging earnings.
Reported Earnings • May 13First quarter 2022 earnings: EPS and revenues miss analyst expectationsFirst quarter 2022 results: US$0.01 loss per share (down from US$0.009 loss in 1Q 2021). Revenue: US$989.0k (up 59% from 1Q 2021). Net loss: US$8.12m (loss widened 7.9% from 1Q 2021). Revenue missed analyst estimates by 36%. Earnings per share (EPS) also missed analyst estimates by 38%. Over the next year, revenue is forecast to grow 474%, compared to a 169% growth forecast for the industry in Norway. Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has fallen by 29% per year, which means it is significantly lagging earnings.
Reported Earnings • Feb 28Full year 2021 earnings: EPS in line with analyst expectations despite revenue beatFull year 2021 results: US$0.035 loss per share (vs US$0.035 loss in FY 2020). Net loss: US$32.6m (loss widened 22% from FY 2020). Revenue exceeded analyst estimates by 2.4%. Over the next year, revenue is forecast to grow 483%, compared to a 216% growth forecast for the industry in Norway. Over the last 3 years on average, earnings per share has increased by 20% per year but the company’s share price has fallen by 21% per year, which means it is significantly lagging earnings.
Breakeven Date Change • Jan 01Forecast to breakeven in 2024The 2 analysts covering IDEX Biometrics expect the company to break even for the first time. New consensus forecast suggests the company will make a profit of US$200.0k in 2024. Average annual earnings growth of 55% is required to achieve expected profit on schedule.
Reported Earnings • Nov 06Third quarter 2021 earnings released: US$0.01 loss per share (vs US$0.009 loss in 3Q 2020)The company reported a solid third quarter result with improved revenues and control over costs, although losses increased. Third quarter 2021 results: Revenue: US$732.0k (up 195% from 3Q 2020). Net loss: US$7.47m (loss widened 10.0% from 3Q 2020). Over the last 3 years on average, earnings per share has increased by 21% per year but the company’s share price has fallen by 13% per year, which means it is significantly lagging earnings.
分析記事 • Oct 23We Think IDEX Biometrics (OB:IDEX) Needs To Drive Business Growth CarefullyJust because a business does not make any money, does not mean that the stock will go down. For example, biotech and...
Reported Earnings • Aug 13Second quarter 2021 earnings released: US$0.01 loss per share (vs US$0.009 loss in 2Q 2020)The company reported a solid second quarter result with improved revenues and control over costs, although losses increased. Second quarter 2021 results: Revenue: US$697.0k (up 368% from 2Q 2020). Net loss: US$7.24m (loss widened 13% from 2Q 2020). Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has fallen by 23% per year, which means it is significantly lagging earnings.
分析記事 • May 14We Think IDEX Biometrics (OB:IDEX) Needs To Drive Business Growth CarefullyWe can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...
Reported Earnings • May 13First quarter 2021 earnings released: US$0.01 loss per share (vs US$0.009 loss in 1Q 2020)First quarter 2021 results: Net loss: US$7.53m (loss widened 19% from 1Q 2020). Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has fallen by 19% per year, which means it is significantly lagging earnings.
Executive Departure • May 04Advisor has left the companyOn the 1st of May, Derek D'Antilio's tenure as Advisor ended after less than a year in the role. As of December 2020, Derek personally held 681.93k shares (kr2.0m worth at the time). Derek is the only executive to leave the company over the last 12 months.
Reported Earnings • Apr 25Full year 2020 earnings released: US$0.035 loss per share (vs US$0.054 loss in FY 2019)Full year 2020 results: Net loss: US$26.8m (loss narrowed 18% from FY 2019). Over the last 3 years on average, earnings per share has increased by 16% per year but the company’s share price has fallen by 13% per year, which means it is significantly lagging earnings.
分析記事 • Mar 03Chief Executive Officer Vincent Graziani Just Bought 19% More Shares In IDEX Biometrics ASA (OB:IDEX)Those following along with IDEX Biometrics ASA ( OB:IDEX ) will no doubt be intrigued by the recent purchase of shares...
Recent Insider Transactions • Mar 03Chief Executive Officer recently bought kr37m worth of stockOn the 1st of March, Vincent Graziani bought around 150k shares on-market at roughly kr246 per share. This was the largest purchase by an insider in the last 3 months. Vincent has been a buyer over the last 12 months, purchasing a net total of kr38m worth in shares.
分析記事 • Feb 27Did The Underlying Business Drive IDEX Biometrics' (OB:IDEX) Lovely 324% Share Price Gain?For many, the main point of investing in the stock market is to achieve spectacular returns. When an investor finds a...
Reported Earnings • Feb 26Full year 2020 earnings released: US$0.03 loss per share (vs US$0.055 loss in FY 2019)Full year 2020 results: Net loss: US$26.8m (loss narrowed 18% from FY 2019). Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has fallen by 17% per year, which means it is significantly lagging earnings.
Analyst Estimate Surprise Post Earnings • Feb 26Revenue and earnings miss expectationsRevenue missed analyst estimates by 3.8%. Earnings per share (EPS) also missed analyst estimates by 16%. Over the next year, revenue is forecast to grow 357%, compared to a 235% growth forecast for the Electronic industry in Norway.
Is New 90 Day High Low • Feb 22New 90-day high: kr3.33The company is up 70% from its price of kr1.95 on 24 November 2020. The Norwegian market is up 11% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Electronic industry, which is up 27% over the same period.
Is New 90 Day High Low • Dec 28New 90-day high: kr3.10The company is up 49% from its price of kr2.08 on 29 September 2020. The Norwegian market is up 12% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Electronic industry, which is up 7.0% over the same period.